These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26484998)

  • 1. Blending Quality Improvement and Research Methods for Implementation Science, Part II: Analysis of the Quality of Implementation.
    Pokorney SD; Taft C; Granger BB
    AACN Adv Crit Care; 2015; 26(4):366-71. PubMed ID: 26484998
    [No Abstract]   [Full Text] [Related]  

  • 2. Blending Quality Improvement and Research Methods for Implementation Science, Part III: Analysis of the Effectiveness of Implementation.
    Granger BB; Pokorney SD; Taft C
    AACN Adv Crit Care; 2016 Feb; 27(1):103-10. PubMed ID: 26909460
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral anticoagulation for atrial fibrillation in Italy: where do we stand?].
    Di Pasquale G; Riva L; Zagnoni S
    G Ital Cardiol (Rome); 2014 Feb; 15(2):123-5. PubMed ID: 24625852
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticoagulation versus aspirin for geriatric patients with atrial fibrillation: is there still any doubt?
    Corvol A; Legendre C; Jean C; Lahjibi-Paulet H; Saint-Jean O; Somme D
    J Am Geriatr Soc; 2010 Feb; 58(2):398-400. PubMed ID: 20370874
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation.
    Agirbasli M
    J Thromb Thrombolysis; 2018 Nov; 46(4):570. PubMed ID: 30046961
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient?
    Prisco D; Cenci C; Silvestri E; Ciucciarelli L; Di Minno G
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):512-9. PubMed ID: 25798903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: a meta-analysis of randomized controlled trials.
    Fauchier L; Clementy N; Saint-Etienne C; Simeon E; Angoulvant D; Bernard-Brunet A
    Int J Cardiol; 2014 Apr; 173(1):122-4. PubMed ID: 24636544
    [No Abstract]   [Full Text] [Related]  

  • 8. [Old patient with atrial fibrillation: do you too hesitate to use anticoagulants?].
    MMW Fortschr Med; 2006 Sep; 148(38):14. PubMed ID: 17036954
    [No Abstract]   [Full Text] [Related]  

  • 9. New oral anticoagulants for nonvalvular atrial fibrillation in the elderly: Limited applicability in primary care.
    Opstelten W; van den Donk M; Kuijpers T; Burgers J
    Eur J Gen Pract; 2015 Jun; 21(2):145-9. PubMed ID: 25495417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial hemorrhage with target specific oral anticoagulants in patients with atrial fibrillation: An updated meta-analysis of randomized controlled trials.
    Kundu A; Sen P; Sardar P; Chatterjee S; Kapoor A; McManus DD
    Int J Cardiol; 2016 Jan; 203():1000-2. PubMed ID: 26630621
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel oral anticoagulants for stroke prevention in atrial fibrillation.
    Taylor J
    Eur Heart J; 2012 Jun; 33(12):1419-20. PubMed ID: 22880211
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulants in non-rheumatic atrium fibrillation].
    van Zuilen EV
    Ned Tijdschr Geneeskd; 1991 Nov; 135(47):2204-8. PubMed ID: 1956452
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral anticoagulants for stroke prevention in atrial fibrillation.
    Senoo K; Lane DA; Lip GY
    Curr Probl Cardiol; 2014 Sep; 39(9):319-44. PubMed ID: 25194766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Belgian Improvement Study in Oral Anticoagulant Therapy: a randomized clinical trial.
    Katona A; Mark L
    Eur Heart J; 2006 Jun; 27(11):1382. PubMed ID: 16595524
    [No Abstract]   [Full Text] [Related]  

  • 15. Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?
    Foley J; Lip GY
    Int J Clin Pract; 2012 May; 66(5):422-4. PubMed ID: 22512602
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-valvular atrial fibrillation: potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants.
    Boriani G; Cimaglia P; Fantecchi E; Mantovani V; Ziacchi M; Valzania C; Martignani C; Biffi M; Diemberger I
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):491-6. PubMed ID: 25575278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [As cardiologists how much do we take into account the guideline recommendations while prescribing oral anticoagulants to patients with atrial fibrillation our clinical practice? A striking result!].
    Ertaş F
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):726-7. PubMed ID: 24172806
    [No Abstract]   [Full Text] [Related]  

  • 18. Updated NICE guideline: management of atrial fibrillation (2014).
    Senoo K; Lau YC; Lip GY
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1037-40. PubMed ID: 25059099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Heart Rhythm Association launches a practical guide on new oral anticoagulants in atrial fibrillation.
    Taylor J
    Eur Heart J; 2013 Mar; 34(11):791. PubMed ID: 23492939
    [No Abstract]   [Full Text] [Related]  

  • 20. New oral anticoagulants for non-valvular atrial fibrillation: harder to handle than expected.
    Shurlock B
    Eur Heart J; 2014 Jul; 35(28):1825-36. PubMed ID: 25049157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.